Principal Investigator
Maria Abreu
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20170052
National Clinical Trials Identifier
NCT02958865
Clinical Trial Summary
The purpose of this study is to determine whether PF-06651600 and PF-06700841 are effective
in treatment of moderate to severe ulcerative colitis.
Phase
Phase 2
Funding Agency/Sponsor
Industry
Disease
Other
Enrollment Eligibility
Inclusion Criteria:
- Diagnosis of ulcerative colitis for greater than/equal to 3 months.
- Moderate to severe active ulcerative colitis
- Inadequate response to, loss of response to, or intolerance to at least one
conventional therapy for UC.
Exclusion Criteria:
- Pregnant or breastfeeding
- Clinical findings suggestive of Crohn's Disease
- History of bowel surgery within 6 months
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu
Get detailed information on ClinicalTrials.Gov